Class IIITerminatedD-0978-2018
Drug recall · July 18, 2018
Triamterene and Hydrochlorothiazide Tablets recall
Why: Subpotent Drug
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Triamterene and Hydrochlorothiazide Tablets, USP 37.5 mg/25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals, Inc. Morgantown, WV 26505, NDC 0378-1352-01
- Lots / codes
Lot #: 2007979, Exp. 11/30/2020
- Quantity
- 28,436 bottles
- Company
- Mylan Pharmaceuticals Inc., Morgantown, WV
- Distribution
- Nationwide within the United States
- Initiated
- July 9, 2018 · Voluntary: Firm initiated
- Classified
- July 24, 2018
- Reported
- July 18, 2018
- Ended
- January 16, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.